HTR1A and status epilepticus: A study administering a 5-HT1A agonist in lithium-pilocarpine–induced status epilepticus in mice showed that hippocampal 5-HT1A receptors are involved in reducing seizure severity, whereas those located in extrahippocampal areas contribute to delayed seizure propagation (Yang et al., 2014).